HONG KONG – China’s largest producer of hepatitis B vaccine (HBV) was allowed to put its products back on market after the China Food and Drug Administration (CFDA) cleared it of any links to the deaths of 17 children. Read More

SHANGHAI – Bayer AG has signed a three-year partnership with Peking University (known locally as Beida) to establish the Bayer Healthcare/Peking University Center of Translational Research for Drug Discovery (BPC/TRDD). Read More

Scientists from the Taiwanese Academia Sinica have reported that they have developed an influenza vaccine that was broadly protective in mice and ferrets by focusing not on the amino acid sequence of the vaccine antigen, but on how many sugars were attached to those amino acids. Read More

SHANGHAI – Xin Chun Kuai Le! Kung Hei Fat Choi! The first is Mandarin for “Happy Spring Festival.” The second is the Cantonese equivalent of “Wishing you prosperity.” Read More

Takeda Pharmaceutical Co. Ltd., of Osaka, Japan, said Takeda Development Center Shanghai and Takeda Development Center Asia Pte. Ltd. started the Phase III TOURMALINE-MM1 global study with the oral proteasome inhibitor, ixazomib, in relapsed and/or refractory multiple myeloma. Read More

Daiichi Sankyo Co. Ltd., of Tokyo, appointed Mahmoud Ghazzi global head of drug development. Ghazzi is now responsible for all drug development-related activities globally and will maintain his current role as head of the Americas Region. Read More

Qu Biologics Inc., of Vancouver, British Columbia, has been granted Australian Patent No. 2007308721, related to tissue-targeted activation of the immune response for cancer treatment. Read More